Skip to main content

Advertisement

SpringerLink
Log in

CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma

  • Pancreas
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to investigate the relationship between CT imaging phenotypes and genetic and biological characteristics in pancreatic ductal adenocarcinoma (PDAC).

Methods

In this retrospective study, consecutive patients between April 2015 and June 2016 who underwent PDAC resection were included if previously consented to a targeted sequencing protocol. Mutation status of known PDAC driver genes (KRAS, TP53, CDKN2A, and SMAD4) in the primary tumor was determined by targeted DNA sequencing and results were validated by immunohistochemistry (IHC). Radiomic features of the tumor were extracted from the preoperative CT scan and used to predict genotype and stromal content.

Results

The cohort for analysis consisted of 35 patients. Genomic and IHC analysis revealed alterations in KRAS in 34 (97%) patients, and changes in expression of CDKN2A in 29 (83%), SMAD4 in 16 (46%), and in TP53 in 29 (83%) patients. Models created from radiomic features demonstrated associations with SMAD4 status and the number of genes altered. The number of genes altered was the only significant predictor of overall survival (p = 0.016). By linear regression analysis, a prediction model for stromal content achieved an R2 value of 0.731 with a root mean square error of 19.5.

Conclusions

In this study, we demonstrate that in PDAC SMAD4 status and tumor stromal content can be predicted using radiomic analysis of preoperative CT imaging. These data show an association between resectable PDAC imaging features and underlying tumor biology and their potential for future precision medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66 (1):7-30. https://doi.org/10.3322/caac.21332

    Article  PubMed  Google Scholar 

  2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research 74 (11):2913-2921

    Article  CAS  PubMed  Google Scholar 

  3. Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD, Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES, Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Grutzmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA, Australian Pancreatic Cancer Genome I, Gill AJ, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SM (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518 (7540):495-501. https://doi.org/10.1038/nature14169

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu Q, Nones K, Fink JL, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Mead RS, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Mawson A, Samra JS, Kench JG, Lovell JA, Daly RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Australian Pancreatic Cancer Genome I, Kakkar N, Zhao F, Wu YQ, Wang M, Muzny DM, Fisher WE, Brunicardi FC, Hodges SE, Reid JG, Drummond J, Chang K, Han Y, Lewis LR, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhopadhyay D, Tsao MS, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Capelli P, Corbo V, Scardoni M, Tortora G, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespada DA, Wessels LF, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Wheeler DA, Pearson JV, McPherson JD, Gibbs RA, Grimmond SM (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491 (7424):399-405. https://doi.org/10.1038/nature11547

  5. Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, Nourse C, Murtaugh LC, Harliwong I, Idrisoglu S, Manning S, Nourbakhsh E, Wani S, Fink L, Holmes O, Chin V, Anderson MJ, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Xu Q, Wilson PJ, Cloonan N, Kassahn KS, Taylor D, Quek K, Robertson A, Pantano L, Mincarelli L, Sanchez LN, Evers L, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Pajic M, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Lovell JA, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Moran-Jones K, Jamieson NB, Graham JS, Duthie F, Oien K, Hair J, Grutzmann R, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Rusev B, Capelli P, Salvia R, Tortora G, Mukhopadhyay D, Petersen GM, Australian Pancreatic Cancer Genome I, Munzy DM, Fisher WE, Karim SA, Eshleman JR, Hruban RH, Pilarsky C, Morton JP, Sansom OJ, Scarpa A, Musgrove EA, Bailey UM, Hofmann O, Sutherland RL, Wheeler DA, Gill AJ, Gibbs RA, Pearson JV, Waddell N, Biankin AV, Grimmond SM (2016) Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531 (7592):47-52. https://doi.org/10.1038/nature16965

  6. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE (1994) p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer research 54 (11):3025-3033

    CAS  PubMed  Google Scholar 

  7. De Bosscher K, Hill CS, Nicolas FJ (2004) Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells. Biochem J 379 (Pt 1):209-216. https://doi.org/10.1042/BJ20031886

    Article  PubMed  PubMed Central  Google Scholar 

  8. Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, Schulick R, Winter J, Herman JM, Laheru D, Klein AP, Vogelstein B, Kinzler KW, Velculescu VE, Hruban RH (2009) SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res 15 (14):4674-4679. https://doi.org/10.1158/1078-0432.CCR-09-0227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Singh P, Srinivasan R, Wig JD (2012) SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma. Pancreas 41 (4):541-546. https://doi.org/10.1097/MPA.0b013e318247d6af

    Article  CAS  PubMed  Google Scholar 

  10. Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, Herman JM, Cameron JL, Yeo CJ, Halushka MK, Eshleman JR, Raben M, Klein AP, Hruban RH, Hidalgo M, Laheru D (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27 (11):1806-1813. https://doi.org/10.1200/JCO.2008.17.7188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Neesse A, Algul H, Tuveson DA, Gress TM (2015) Stromal biology and therapy in pancreatic cancer: a changing paradigm. Gut 64 (9):1476-1484. https://doi.org/10.1136/gutjnl-2015-309304

    Article  CAS  PubMed  Google Scholar 

  12. Ozdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, De Jesus-Acosta A, Sharma P, Heidari P, Mahmood U, Chin L, Moses HL, Weaver VM, Maitra A, Allison JP, LeBleu VS, Kalluri R (2014) Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer cell 25 (6):719-734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. GGillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology 278 (2):563-577. https://doi.org/10.1148/radiol.2015151169

    Article  PubMed  Google Scholar 

  14. Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, Sutton EJ, Morris EA (2018) Background, current role, and potential applications of radiogenomics. J Magn Reson Imaging 47 (3):604-620. https://doi.org/10.1002/jmri.25870

    Article  PubMed  Google Scholar 

  15. Eilaghi A, Baig S, Zhang Y, Zhang J, Karanicolas P, Gallinger S, Khalvati F, Haider MA (2017) CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis. BMC Med Imaging 17 (1):38. https://doi.org/10.1186/s12880-017-0209-5

    Article  PubMed  PubMed Central  Google Scholar 

  16. Attiyeh MA, Chakraborty J, Doussot A, Langdon-Embry L, Mainarich S, Gonen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Simpson AL, Do RK (2018) Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. Ann Surg Oncol 25 (4):1034-1042. https://doi.org/10.1245/s10434-017-6323-3

    Article  PubMed  PubMed Central  Google Scholar 

  17. Chakraborty J, Langdon-Embry L, Cunanan KM, Escalon JG, Allen PJ, Lowery MA, O'Reilly EM, Gonen M, Do RG, Simpson AL (2017) Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients. PLoS One 12 (12):e0188022. https://doi.org/10.1371/journal.pone.0188022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Yun G, Kim YH, Lee YJ, Kim B, Hwang JH, Choi DJ (2018) Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection. Sci Rep 8 (1):7226. https://doi.org/10.1038/s41598-018-25627-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Pinker K, Chin J, Melsaether AN, Morris EA, Moy L (2018) Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment. Radiology 287 (3):732-747. https://doi.org/10.1148/radiol.2018172171

    Article  PubMed  Google Scholar 

  20. Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https://doi.org/10.1038/ncomms5006

    Article  CAS  PubMed  Google Scholar 

  21. Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, Chandramohan R, Liu ZY, Won HH, Scott SN, Brannon AR, O'Reilly C, Sadowska J, Casanova J, Yannes A, Hechtman JF, Yao J, Song W, Ross DS, Oultache A, Dogan S, Borsu L, Hameed M, Nafa K, Arcila ME, Ladanyi M, Berger MF (2015) Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. J Mol Diagn 17 (3):251-264. https://doi.org/10.1016/j.jmoldx.2014.12.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Shen R, Seshan VE (2016) FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res 44 (16):e131. https://doi.org/10.1093/nar/gkw520

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Haralick RM SK, Dinstein I (1973) Textural Features for Image Classification. IEEE Trans Syst Man Cybern SMC-3 (6):610-621

  24. Tang X (1998) Texture information in run-length matrices. IEEE Trans Image Process 7 (11):1602-1609. https://doi.org/10.1109/83.725367

    Article  CAS  PubMed  Google Scholar 

  25. Buczkowski S, Hildgen P, Cartilier L (1998) Measurements of fractal dimension by box-counting: A critical analysis of data scatter. 252 (1-2):23-34. https://doi.org/10.1016/S0378-4371(97)00581-5

    Article  Google Scholar 

  26. Chakraborty J, Rangayyan RM, Banik S, Mukhopadhyay S, Desautels JEL (2012) Statistical measures of orientation of texture for the detection of architectural distortion in prior mammograms of interval-cancer. J Electron Imaging 21 (3):12

    Article  Google Scholar 

  27. Ojala T, Pietikäinen M, Harwood D (1996) A Comparative Study of Texture Measures with Classification Based on Feature Distributions. 29 (1):51-59. https://doi.org/10.1016/0031-3203(95)00067-4

    Article  Google Scholar 

  28. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53 (4):549-554

    Article  CAS  PubMed  Google Scholar 

  29. Wood LD, Hruban RH (2012) Pathology and molecular genetics of pancreatic neoplasms. Cancer J 18 (6):492-501. https://doi.org/10.1097/PPO.0b013e31827459b6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8 (1):27-32. https://doi.org/10.1038/ng0994-27

    Article  CAS  PubMed  Google Scholar 

  31. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG (1997) Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer research 57 (15):3126-3130

    CAS  PubMed  Google Scholar 

  32. Sandrasegaran K, Lin Y, Asare-Sawiri M, Taiyini T, Tann M (2019) CT texture analysis of pancreatic cancer. Eur Radiol 29 (3):1067-1073. https://doi.org/10.1007/s00330-018-5662-1

    Article  PubMed  Google Scholar 

  33. Cozzi L, Comito T, Fogliata A, Franzese C, Franceschini D, Bonifacio C, Tozzi A, Di Brina L, Clerici E, Tomatis S, Reggiori G, Lobefalo F, Stravato A, Mancosu P, Zerbi A, Sollini M, Kirienko M, Chiti A, Scorsetti M (2019) Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma. PLoS One 14 (1):e0210758. https://doi.org/10.1371/journal.pone.0210758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Choi SH, Kim HJ, Kim KW, An S, Hong SM, Kim SC, Kim MH (2017) DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics. Br J Radiol 90(1073):20160403. https://doi.org/10.1259/bjr.20160403

    Article  PubMed  PubMed Central  Google Scholar 

  35. Birkbak NJ, Kochupurakkal B, Izarzugaza JM, Eklund AC, Li Y, Liu J, Szallasi Z, Matulonis UA, Richardson AL, Iglehart JD, Wang ZC (2013) Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations. PLoS One 8 (11):e80023. https://doi.org/10.1371/journal.pone.0080023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Park JH, Kim TM, Keam B, Jeon YK, Lee SH, Kim DW, Chung DH, Kim YT, Kim YW, Heo DS (2013) Tumor burden is predictive of survival in patients with non-small-cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib. Clin Lung Cancer 14 (4):383-389. https://doi.org/10.1016/j.cllc.2012.10.007

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was funded in part through the National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748, the David M. Rubenstein Center for Pancreatic Research, and Cycle for Survival.

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Marc A. Attiyeh, Jayasree Chakraborty, Caitlin A. McIntyre, Yuting Chou, Vinod P. Balachandran, T. Peter Kingham, Michael I. D’Angelica, Jeffrey A. Drebin, William R. Jarnagin, Peter J. Allen & Amber L. Simpson

  2. Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Rajya Kappagantula, Gokce Askan, Olca Basturk & Christine A. Iacobuzio-Donahue

  3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Kenneth Seier & Mithat Gonen

  4. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, C-276F, New York, NY, 10065, USA

    Richard K. Do

Authors
  1. Marc A. Attiyeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jayasree Chakraborty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caitlin A. McIntyre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rajya Kappagantula
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuting Chou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gokce Askan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kenneth Seier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mithat Gonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Olca Basturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Vinod P. Balachandran
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. T. Peter Kingham
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Michael I. D’Angelica
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jeffrey A. Drebin
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. William R. Jarnagin
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Peter J. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Christine A. Iacobuzio-Donahue
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Amber L. Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Richard K. Do
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard K. Do.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 111 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Attiyeh, M.A., Chakraborty, J., McIntyre, C.A. et al. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Abdom Radiol 44, 3148–3157 (2019). https://doi.org/10.1007/s00261-019-02112-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-019-02112-1

Keywords

Search

Navigation